Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Policy Change for Deep Vein Thrombosis: Effects on Length of Stay and Hospitalization Costs of Moving From Warfarin to Direct Oral Anticoagulants.

Porath AD, Clodfelter S, Slaton T, Bookhart BK, Kozma CM, Rand ML, Bloch MJ.

Clin Ther. 2019 Feb;41(2):269-279. doi: 10.1016/j.clinthera.2018.12.006. Epub 2019 Jan 11.

PMID:
30642614
2.

A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs.

Bowen JD, Kozma CM, Grosso MM, Phillips AL.

Mult Scler J Exp Transl Clin. 2018 Dec 17;4(4):2055217318819031. doi: 10.1177/2055217318819031. eCollection 2018 Oct-Dec.

3.

A retrospective analysis to identify predictors of COPD-related rehospitalization.

Roberts MH, Clerisme-Beaty E, Kozma CM, Paris A, Slaton T, Mapel DW.

BMC Pulm Med. 2016 Apr 30;16(1):68. doi: 10.1186/s12890-016-0231-3.

4.

The effect of age and sex on cost of inpatient facility encounters among patients with multiple sclerosis.

Kozma CM, Meletiche DM, Phillips AL.

J Med Econ. 2015;18(9):704-10. doi: 10.3111/13696998.2015.1044995. Epub 2015 Jun 12.

PMID:
25913916
5.

Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.

Muser E, Kozma CM, Benson CJ, Mao L, Starr HL, Alphs L, Fastenau J.

J Med Econ. 2015;18(8):637-45. doi: 10.3111/13696998.2015.1037307. Epub 2015 May 6.

PMID:
25851616
6.

Effectiveness of step therapy policies for specialty pharmaceuticals in immune disorders.

Kozma CM, Ingham M, Paris A, Ellis L.

J Med Econ. 2015;18(8):646-53. doi: 10.3111/13696998.2015.1035278. Epub 2015 Apr 24.

PMID:
25830699
7.

Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.

Phillips AL, Kozma CM, Locklear JC.

Value Health. 2014 Nov;17(7):A400. doi: 10.1016/j.jval.2014.08.910. Epub 2014 Oct 26. No abstract available.

8.

Healthcare costs for Crohn's disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence.

Feagan BG, Kozma CM, Slaton TL, Olson WH, Wan GJ.

J Med Econ. 2014 Dec;17(12):872-80. doi: 10.3111/13696998.2014.950669. Epub 2014 Aug 27.

PMID:
25162777
9.
10.

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR.

Paris A, Kozma CM, Chow W, Patel AM, Mody SH, Kim MS.

Am Health Drug Benefits. 2013 Nov;6(9):567-75.

11.

Adherence patterns for abiraterone acetate and concomitant prednisone use in patients with prostate cancer.

Lafeuille MH, Grittner AM, Lefebvre P, Ellis L, McKenzie RS, Slaton T, Kozma C.

J Manag Care Spec Pharm. 2014 May;20(5):477-84.

12.

Complexity of pain management among patients with nociceptive or neuropathic neck, back, or osteoarthritis diagnoses.

Kozma CM, Provenzano DA, Slaton TL, Patel AA, Benson CJ.

J Manag Care Spec Pharm. 2014 May;20(5):455-66b.

13.

Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy.

Wan GJ, Kozma CM, Slaton TL, Olson WH, Feagan BG.

J Med Econ. 2014 Jun;17(6):384-93. doi: 10.3111/13696998.2014.909436. Epub 2014 Apr 16.

PMID:
24673303
14.

Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.

Kozma CM, Dickson M, Phillips AL, Meletiche DM.

Patient Prefer Adherence. 2013 Jun 12;7:509-16. doi: 10.2147/PPA.S40736. Print 2013.

15.

Cost and utilization of healthcare services for hip and knee replacement.

Kozma CM, Slaton T, Paris A, Edgell ET.

J Med Econ. 2013 Jul;16(7):888-96. doi: 10.3111/13696998.2013.802695. Epub 2013 May 23.

PMID:
23647482
16.

Trends in neutropenia-related inpatient events.

Kozma CM, Dickson M, Chia V, Legg J, Barron R.

J Oncol Pract. 2012 May;8(3):149-55. doi: 10.1200/JOP.2011.000360. Epub 2012 Jan 31.

17.

Opioids before and after initiation of pregabalin in patients with diabetic peripheral neuropathy.

Kozma CM, Benson C, Slaton TL, Kim MS, Vorsanger GJ.

Curr Med Res Opin. 2012 Sep;28(9):1485-96. Epub 2012 Aug 2.

PMID:
22856535
18.

The association of self-monitoring of blood glucose use with medication adherence and glycemic control in patients with type 2 diabetes initiating non-insulin treatment.

Virdi N, Daskiran M, Nigam S, Kozma C, Raja P.

Diabetes Technol Ther. 2012 Sep;14(9):790-8. doi: 10.1089/dia.2012.0047. Epub 2012 Jul 9.

PMID:
22775240
19.

Association between sitagliptin adherence and self-monitoring of blood glucose.

Nigam S, Virdi NS, Daskiran M, Kozma CM, Paris A, Dickson WM.

J Diabetes Sci Technol. 2012 May 1;6(3):555-62.

20.

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study.

Kozma CM, Paris AL, Plauschinat CA, Slaton T, Mackowiak JI.

BMC Pulm Med. 2011 Dec 22;11:61. doi: 10.1186/1471-2466-11-61.

21.
22.

Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results.

Macfadden W, DeSouza C, Crivera C, Kozma CM, Dirani RD, Mao L, Rodriguez SC.

BMC Psychiatry. 2011 Oct 14;11:167. doi: 10.1186/1471-244X-11-167.

23.

Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE).

Kozma CM, Slaton T, Dirani R, Fastenau J, Gopal S, Hough D.

Curr Med Res Opin. 2011 Aug;27(8):1603-11. doi: 10.1185/03007995.2011.595000. Epub 2011 Jun 22.

PMID:
21696265
24.

Genetic drift. The ancient Egyptian dwarfs of the pyramids: the high official and the female worker.

Kozma C, Sarry El Din AM, El Shafy El Banna RA, El Samie Kandeel WA, Lachman R.

Am J Med Genet A. 2011 Aug;155A(8):1817-24. doi: 10.1002/ajmg.a.34038. Epub 2011 Jun 14.

PMID:
21674771
25.

Methotrexate and misoprostol teratogenicity: further expansion of the clinical manifestations.

Kozma C, Ramasethu J.

Am J Med Genet A. 2011 Jul;155A(7):1723-8. doi: 10.1002/ajmg.a.34037. Epub 2011 Jun 10.

PMID:
21671374
26.

X-ray illumination of the ejecta of supernova 1987A.

Larsson J, Fransson C, Ostlin G, Gröningsson P, Jerkstrand A, Kozma C, Sollerman J, Challis P, Kirshner RP, Chevalier RA, Heng K, McCray R, Suntzeff NB, Bouchet P, Crotts A, Danziger J, Dwek E, France K, Garnavich PM, Lawrence SS, Leibundgut B, Lundqvist P, Panagia N, Pun CS, Smith N, Sonneborn G, Wang L, Wheeler JC.

Nature. 2011 Jun 8;474(7352):484-6. doi: 10.1038/nature10090.

PMID:
21654749
27.

Rates of venous thromboembolism among patients with major surgery for cancer.

Hammond J, Kozma C, Hart JC, Nigam S, Daskiran M, Paris A, Mackowiak JI.

Ann Surg Oncol. 2011 Nov;18(12):3240-7. doi: 10.1245/s10434-011-1723-2. Epub 2011 May 17.

PMID:
21584837
28.

Comparative hospital economics and patient presentation: vertebroplasty and kyphoplasty for the treatment of vertebral compression fracture.

Mehio AK, Lerner JH, Engelhart LM, Kozma CM, Slaton TL, Edwards NC, Lawler GJ.

AJNR Am J Neuroradiol. 2011 Aug;32(7):1290-4. doi: 10.3174/ajnr.A2502. Epub 2011 May 5.

29.

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium.

Lambert T, Olivares JM, Peuskens J, DeSouza C, Kozma CM, Otten P, Crivera C, Jacobs A, Macfadden W, Mao L, Rodriguez SC, Dirani R, Akhras KS.

Ann Gen Psychiatry. 2011 Apr 4;10:10. doi: 10.1186/1744-859X-10-10.

30.

Change in employment status over 52 weeks in patients with schizophrenia: an observational study.

Kozma C, Dirani R, Canuso C, Mao L.

Curr Med Res Opin. 2011 Feb;27(2):327-33. doi: 10.1185/03007995.2010.541431. Epub 2010 Dec 15.

PMID:
21155708
31.

Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP).

Kozma CM, Dickson M, Raut MK, Mody S, Fisher AC, Schein JR, Mackowiak JI.

J Med Econ. 2010;13(4):719-27. doi: 10.3111/13696998.2010.536350. Epub 2010 Nov 22.

PMID:
21091099
32.

Genetic Drift. The ancient Egyptian dwarfs of the Walters Art Museum.

Kozma C.

Am J Med Genet A. 2010 Oct;152A(10):2556-62. doi: 10.1002/ajmg.a.33616.

PMID:
20799327
33.
35.

Skeletal dysplasia in ancient Egypt.

Kozma C.

Am J Med Genet A. 2008 Dec 1;146A(23):3104-12. doi: 10.1002/ajmg.a.32501.

PMID:
19006207
36.

Potential drug-drug interactions with antiepileptic drugs in Medicaid recipients.

Dickson M, Bramley TJ, Kozma C, Doshi D, Rupnow MF.

Am J Health Syst Pharm. 2008 Sep 15;65(18):1720-6. doi: 10.2146/ajhp070508.

PMID:
18768998
38.

Antidepressant prescribing patterns: a comparison of blacks and whites in a medicaid population.

Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE.

Clin Drug Investig. 1998;16(2):135-40.

PMID:
18370531
39.

Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.

Agnihotri P, Telfer M, Butt Z, Jella A, Cella D, Kozma CM, Ahuja M, Riaz S, Akamah J.

J Am Geriatr Soc. 2007 Oct;55(10):1557-65. Epub 2007 Aug 14.

PMID:
17697104
40.

Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine.

Ramaswamy K, Kozma CM, Nasrallah H.

Drug Saf. 2007;30(7):589-99.

PMID:
17604410
41.

Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.

Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL.

Eur Urol. 2007 Sep;52(3):850-8. Epub 2007 Apr 19.

PMID:
17467889
42.

Reliability and validity of the Incontinence Quality of Life questionnaire in patients with neurogenic urinary incontinence.

Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron R.

Arch Phys Med Rehabil. 2007 May;88(5):646-52.

PMID:
17466735
43.

Principles for developing effective disease-state management programs.

Kozma CM.

Manag Care Interface. 2007 Mar;20(3):58-9. No abstract available.

PMID:
17458484
44.

Educating patients on hype versus science.

Kozma CM.

Manag Care Interface. 2007 Feb;20(2):41-2. No abstract available.

PMID:
17405581
45.

Low-tech considerations in disease management.

Kozma CM.

Manag Care Interface. 2007 Jan;20(1):64-5. No abstract available.

PMID:
17310654
46.

Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.

Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC.

Nat Genet. 2007 Mar;39(3):359-65. Epub 2007 Feb 4. Erratum in: Nat Genet. 2008 Jul;40(7):927.

PMID:
17277775
47.

The Democratic Party's National Platform on Health Care.

Kozma CM.

Manag Care Interface. 2006 Dec;19(12):52, 55. No abstract available.

PMID:
17274483
48.

Medical tourism: a role disease management?

Kozma CM.

Manag Care Interface. 2006 Nov;19(11):35-6. No abstract available.

PMID:
17137240
49.

Focus on methods: chi-square analysis.

Kozma CM.

Manag Care Interface. 2006 Oct;19(10):49-50. No abstract available.

PMID:
17117599
50.

Predictive modeling: a more creative approach for disease management programs.

Kozma CM.

Manag Care Interface. 2006 Sep;19(9):27-8. No abstract available.

PMID:
17017309

Supplemental Content

Support Center